Evidence map›Paper›PMID 31884933›Full record

ReviewRecent patents on drug delivery & formulation2019

Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective.

Zufika Qamar, Farheen Fatima Qizilbash, Mohammad Kashif Iqubal, Asgar Ali, Jasjeet Kaur Narang, Javed Ali, Sanjula Baboota

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Recent patents on drug delivery & formulation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zufika QamarDepartment of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi - 110062, India.
Farheen Fatima QizilbashDepartment of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi - 110062, India.
Mohammad Kashif IqubalDepartment of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi - 110062, India.
Asgar AliDepartment of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi - 110062, India.
Jasjeet Kaur NarangDepartment of Pharmaceutics, Khalsa College of Pharmacy, Amritsar, Punjab-143001, India.
Javed AliDepartment of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi - 110062, India.
Sanjula BabootaDepartment of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi - 110062, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The structure of the eye is very complex in nature which makes it a challenging task for pharmaceutical researchers to deliver the drug at the desired sites via different routes of administration. The development of the nano-based system helped in delivering the drug in the desired concentration. Improvement in penetration property, bioavailability, and residence time has all been achieved by encapsulating drugs into liposomes, dendrimers, solid lipid nanoparticle, nanostructured lipid carrier, nanoemulsion, and nanosuspension. This review puts emphasis on the need for nanomedicine for ocular drug delivery and recent developments in the field of nanomedicine along with recent patents published in the past few years.

Indexed as

Drug Delivery SystemsNanoparticlesAdministration, OphthalmicAnimalsDendrimersDrug CarriersEyeEye DiseasesHumansLipidsLiposomesPatents as TopicDendrimersDrug CarriersLipidsLiposomeshydrogelsinorganic nanoparticlesnanoemulsionnanomedicinenanostructured lipid carriersOcular drug delivery systempatentssolid lipid nanocarriers.

Identifiers

PMID31884933
PMCPMC7499345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.